Aligos Therapeutics, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Aligos Therapeutics, Inc. (ALGS) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $842.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2022-03-10
- Aligos Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2021 was $842.00K, a 9.64% increase from fiscal 2020.
- Aligos Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2020 was $768.00K, a 37.63% increase from fiscal 2019.
- Aligos Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2019 was $558.00K.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2021-12-31 | $842.00K 10-K · filed 2022-03-10 |
| 2020-12-31 | $768.00K 10-K · filed 2022-03-10 |
| 2019-12-31 | $558.00K 10-K · filed 2021-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |